U.S. FDA gets over 48,000 reports of faulty Philips respiratory devices in May-July

1 minute read

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo/File Photo

Register now for FREE unlimited access to Reuters.com

Aug 16 (Reuters) - The U.S. Food and Drug Administration said it had received more than 48,000 reports of faulty Dutch medical equipment maker Philips' (PHG.AS) ventilators and respiratory devices between May and July, which included 44 deaths.

This was more than twice the number of reports it had received in over a year until April, the agency said on Tuesday.

Register now for FREE unlimited access to Reuters.com
Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur

Our Standards: The Thomson Reuters Trust Principles.